Cargando…
Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
Thrombosis and bleeding are significant contributors to morbidity and mortality in patients with hematological cancer, and the impact of altered fibrinolysis on bleeding and thrombosis risk is poorly understood. In this prospective cohort study, we investigated the dynamics of fibrinolysis in patien...
Autores principales: | Bønløkke, Søren Thorgaard, Fenger-Eriksen, Christian, Ommen, Hans Beier, Hvas, Anne-Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694522/ https://www.ncbi.nlm.nih.gov/pubmed/37756519 http://dx.doi.org/10.1182/bloodadvances.2023011379 |
Ejemplares similares
-
Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy
por: Bønløkke, Søren Thorgaard, et al.
Publicado: (2023) -
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
por: Yamasaki-Morita, Makiko, et al.
Publicado: (2022) -
Catheter‐directed thrombolysis for massive deep vein thrombosis in an adolescent with severe antithrombin deficiency
por: Bønløkke, Søren Thorgaard, et al.
Publicado: (2022) -
Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017) -
Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assays
por: Driever, Ellen G., et al.
Publicado: (2023)